Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
REMEDY FOR NEURODEGENERATIVE DISEASES
No-Receipt date
2005-02109 - 26/05/2005
No-Filing date
20050401799 - 09/06/2005
No-Granting date
3053837 - 30/06/2005
No-EPO application date
98961430.0 - 21/12/1998
No-EPO granting date
1040830 - 08/06/2005
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2005 - 12/07/2005
Expiration date
22/12/2018
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
JP3693139726/12/1997/JP
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/42
A61K 31/423
A61P 25/16
A61P 25/28
C07D261/20
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
167303
DAINIPPON SUMITOMO PHARMA CO., LTD.
6-8, DOSHO-MACHI 2-CHOME CHUO-KU OSAKA-SHI
OSAKA 541-8524
JAPAN
Inventors
Code
Firstname
Surname
334599
MASUDA, YOSHINOBU
334600
OCHI, YOSHIAKI
Representatives
Code
Firstname
Surname
Address
Town
Zip
742
KONSTANTINOS
KILIMIRIS
XATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2104
ANASTASIOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
11/05/2006
Αλλαγή Επωνυμίας Δικαιούχου (7e801)
Αρ. Πρωτ. 1383/22-2-2006, κωδ. Πληρεξ. 742
128010 Dainippon Pharmaceutical Co., Ltd. 6-8, Dosho-machi 2-chome, Chuo-ku ΙΑΠΩΝΙΑ Osaka-shi, Osaka 541-8524
167303 Dainippon Sumitomo Pharma Co., Ltd. 6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi ΙΑΠΩΝΙΑ Osaka 541-8524
Title Instruments
Date
Operation
Descreption
7/3/2013 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 06/2013 Αρ. ΠΡωτ. Γ.Δ. 500/3.7.2013
Payments history
14 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).